跳至主要内容
临床试验/CTRI/2026/01/101208
CTRI/2026/01/101208尚未招募不适用

A systematic pilot feasibility project to develop newborn screening for cystic fibrosis (CF NBS) in a community in South India

Cystic Fibrosis Foundation1 个研究点 分布在 1 个国家目标入组 20,000 人开始时间: 2026年4月1日

试验速览

阶段
不适用
状态
尚未招募
入组人数
20,000
试验地点
1

研究概览

简要总结

Cystic fibrosis (CF) is a serious inherited condition that affects the lungs and digestive system, often leading to early death if not diagnosed and treated early. Many children in India are diagnosed too late, after developing complications. This study will check feasibility of using a test which is used world over to screen newborns. The test screens babies for possibility of CF  using a small drop of blood collected from the baby’s heel and from the umbilical cord (cord blood). Our goal is to find out if such a newborn screening program is possible in this region and if it could later be used more widely. We will recruit babies born in two hospitals in Vellore. Parents will be asked for consent. Babies with abnormal results will be invited for further testing to confirm if they have CF. All information will be kept confidential, and families will receive support and counselling throughout the process. The proposal has been approved for funding by Cystic Fibrosis Foundation.

研究设计

研究类型
Observational

入排标准

年龄范围
1.00 Day(s) 至 3.00 Day(s)(—)
性别
All

入选标准

  • All live-born infants more than 28 weeks gestational age and more than 1000 grams will be eligible.
  • Infants with meconium ileus will also undergo sweat testing and DNA analysis irrespective of IRT levels.
  • Preterm babies (more than 28 weeks and more than 1000gm) who need admission to neonatal ICU will be recruited after initial stabilisation and treatment of respiratory distress.

排除标准

  • Stillborn infants, and critically ill infants due to potential high IRT-1 levels secondary to perinatal stress, difficulties with IRT-2 sampling, and other medical co-morbidities.
  • Families who are travelling out of Vellore and surrounding districts and cannot come back for retesting (if the need arises) will be excluded.

研究者

申办方类型
Other [Non Profit Organisation]
责任方
Principal Investigator
主要研究者

Dr Sneha Deena Varkki

Christian Medical College, Vellore

研究点 (1)

Loading locations...

相似试验